Phase 1B in TNBC suspended

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

jonzobot

Rank: President [?]

Points: 2527 [?]

Votes: 20 Score: 3.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Phase 1B in TNBC suspended

posted on May 23, 2024 07:18PM

I just checked and it looks like NCT05422794 (treating TNBC in combination with PD1i and chemo) was suspended due to dose limiting toxicity.

This is separate from the Phase 2 that was terminated due to the futility analysis.

Hard luck in this indication. Maybe it will resume some day?

1 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply